WELL Health Technologies Corp. (TSE:WELL) Receives C$6.97 Consensus Target Price from Brokerages

Shares of WELL Health Technologies Corp. (TSE:WELL) have been assigned a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is C$6.97.

Several research firms recently commented on WELL. CIBC boosted their price target on WELL Health Technologies from C$4.75 to C$5.00 in a research note on Friday, August 16th. Ventum Financial cut their price target on WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating on the stock in a research note on Tuesday, October 29th.

WELL Health Technologies Trading Down 0.9 %

Shares of WELL opened at C$4.39 on Thursday. The stock’s 50-day moving average is C$4.43 and its two-hundred day moving average is C$4.30. The stock has a market cap of C$1.09 billion, a PE ratio of 7.70, a P/E/G ratio of -1.93 and a beta of 1.20. WELL Health Technologies has a 12 month low of C$3.41 and a 12 month high of C$5.05. The company has a debt-to-equity ratio of 41.57, a current ratio of 1.25 and a quick ratio of 1.02.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.